| | Index Performance | Index | Sensex | Nifty | Open | 14,277.61 | 4,186.40 | High | 14,326.55 | 4,209.45 | Low | 14,112.53 | 4,153.70 | Today's Cls | 14,162.71 | 4,171.45 | Prev Cls | 14,203.72 | 4,170.00 | Change | -41.01 | 1.45 | % Change | -0.29 | 0.03 | | | Market Indicators | Top Movers (Group A) | Company | Price (Rs) | % chg | Gainers | Lanco Infra | 196.15 | 10.60 | United Phosphorus | 313.10 | 9.36 | HCL Infosys | 186.50 | 7.31 | Suzlon Energy | 1,384.25 | 5.61 | ING Vysya Bank | 253.15 | 5.06 | Losers | SCI | 191.85 | -4.48 | Punjab Tractors | 291.40 | -4.33 | Hexaware | 160.70 | -3.40 | Indo Rama Synthetics | 47.55 | -2.86 | Jindal Stainless | 144.55 | 2.82 | | Market Statistics | - | BSE | NSE | Advances | 1,275 | 783 | Declines | 1,210 | 628 | Unchanged | 86 | 33 | Volume(Nos) | 23.88cr | 34.43cr | | | | | Market Commentary | | Market ends choppy | Led by the heavy selling in IT and metal stocks, the Sensex witnessed a fall and shed 41 points for the day. | The market resumed with a huge positive gap of 74 points on firming trends in global markets, expectations of a further ease in inflation and smart gains in | | | yesterday's trades. The market remained firm but within a range of 14250-14300 in the early trades. The stocks rallied sharply in the afternoon session as India’s inflation rate slipped to 4.8% in the week ended June 2 and touched the intra-day high of 14327. The Sensex shed some gains thereafter but recovered on some buying interest for a while. The Sensex slipped further as selling intensified in frontline, information technology (IT) and metal stocks dragging the index down to enter into negative territory and touch the day's low of 14113. After slipping over 200 points from the day's high the Sensex ended the session by shedding 41 points at 14163. The Nifty closed the session by adding a point at 4171. Although the market fell sharply, the breadth of the market was positive. Of the 2,571 stocks traded on the BSE 1,275 stocks advanced, 1,210 stocks declined and 86 stocks ended unchanged. Among the sectoral indices the BSE IT Index, the BSE Metal Index and the BSE Oil & Gas Index lost around 1% each while the BSE CG Index gained 1.68% and the BSE CD Index added 1.18%. | | Movers & Shakers | - Orchid Chemicals closed in the red despite receiving the tentative approval from the USFDA for its Terbinafine HCL 250mg tablets.
- Hindustan Dorr Oliver rallied sharply on receiving a major order worth Rs85 crore from IOC.
- Aurobindo Pharma slipped despite receiving seventh Cephalosporin approval for its Cefpodoxime proxetil tablets.
- Venus Remedies advanced on successfully filling patent in 48 countries for its second PCT application.
- Indiabulls Real Estate gained on signing a memorandum of understanding with Zublin International GmbH to jointly work on large infrastructure development projects.
| | | The index heavyweights stocks witnessed heavy selling. Tata Steel slumped 2.29% at Rs600, HDFC lost 2.23% at Rs1,785, NTPC shed 1.89% at Rs151, Grasim plunged 1.79% at Rs2,389, Hindalco crumbled by 1.68% at Rs161, TCS declined 1.60% at Rs1,184, Satyam Computer dropped 1.55% at Rs483 while Reliance Industries, Dr Reddy's Lab and Gujarat Ambuja Cement slipped marginally. Select counters, however, managed to buck the downtrend and ended in the green. BHEL rose 2.95% at Rs1,389, Maruti Udyog moved up by 1.62% at Rs740, L&T added 1.29% at Rs1,948 and Tata Motors gained 1.21% at Rs650 and Ranbaxy ended higher by 1.01% at Rs374. IT stocks lost ground on selling pressure. Hexaware dropped 3.40% at Rs161, KLG Systel slumped 3.17% at Rs381, Allsec Technologies declined 3.17% at Rs257, Asian CERC lost 2.81% at Rs195 and Helios & Matheson fell by 2.60% at Rs161. Over 1.41crore IFCI shares changed hands on the BSE followed by GV Films (1 crore shares), IQMS Software (57.36 lakh shares), IKF Technologies (51.30 lakh shares) and Reliance Natural Resources (45.66 lakh shares). Value-wise MIC Electronics registered a turnover of Rs154 crore followed by Reliance Industries (Rs128 crore), Indiabulls Real Estate (Rs127 crore), ICRA (Rs112 crore) and Reliance Capital (Rs89 crore). | | | | | | | | European Indices at 16:15 IST on 15-06-2007 | | | Index | Level | Change (pts) | Change (%) | FTSE 100 | 6690.50 | 40.60 | 0.61 | CAC 40 Index | 6075.68 | 28.45 | 0.47 | DAX Index | 7904.37 | 55.21 | 0.70 | | | | | | | | | | | Asian Indices at close on 15-06-2007 | | | Index | Level | Change (pts) | Change (%) | Nikkei 225 | 17971.49 | 129.20 | 0.72 | Hang Seng | 21017.05 | 149.79 | 0.72 | Kospi Index | 1772.26 | 3.08 | 0.17 | Straits Times | 3581.16 | 7.73 | 0.22 | Jakarta Composite Index | 2120.64 | 12.23 | 0.58 | | | | | | | | To know more about our products and services, click here. | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report. The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com | |